Marshall Wace, LLP Phibro Animal Health Corp Transaction History

Marshall Wace, LLP

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$12.43 - $15.29 $425,541 - $523,453	34,235 New	34,235 $437,000
Q3 2022 Nov 14, 2022	SELL	$12.82 - $20.22 $104,200 - $164,348	-8,128 Reduced 22.15%	28,569 $379,000
Q2 2022 Aug 15, 2022	SELL	$17.89 - $20.47 $1.11 Million - $1.28 Million	-62,302 Reduced 62.93%	36,697 $702,000
Q1 2022 May 16, 2022	BUY	$18.39 - $21.85 $1.82 Million - $2.16 Million	98,999 New	98,999 $1.97 Million
Q4 2021 Feb 14, 2022	SELL	$18.96 - $22.76 $236,146 - $283,475	-12,455 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$20.59 - $30.01 $168,508 - $245,601	-8,184 Reduced 39.65%	12,455 $268,000
Q2 2021 Aug 13, 2021	SELL	$24.15 - $30.08 $605,029 - $753,594	-25,053 Reduced 54.83%	20,639 $596,000
Q1 2021 May 17, 2021	SELL	$19.71 - $25.23 $596,937 - $764,115	-30,286 Reduced 39.86%	45,692 $1.12 Million
Q4 2020 Feb 16, 2021	BUY	$16.44 - $20.2 $901,372 - $1.11 Million	54,828 Added 259.23%	75,978 $1.48 Million
Q3 2020 Nov 16, 2020	BUY	$17.36 - $26.36 $367,164 - $557,514	21,150 New	21,150 $369,000
Q4 2019 Feb 14, 2020	SELL	$21.0 - $24.83 $858,753 - $1.02 Million	-40,893 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$20.34 - $32.66 $1.1 Million - $1.77 Million	-54,199 Reduced 57.0%	40,893 $872,000
Q2 2019 Aug 14, 2019	BUY	$28.03 - $36.85 $2.11 Million - $2.77 Million	75,277 Added 379.9%	95,092 $3.02 Million
Q1 2019 May 14, 2019	SELL	$28.71 - $33.65 $384,914 - $451,145	-13,407 Reduced 40.36%	19,815 $654,000
Q4 2018 Feb 14, 2019	BUY	$31.18 - $44.64 $1.04 Million - $1.48 Million	33,222 New	33,222 $1.07 Million

148

20.4M

Ticker PAHC
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 20,337,600
Market Cap $440M
Description
Phibro Animal Health Corporation develops, manufactures, and supplies a range of animal health and mineral nutrition products for food and companion animals. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets products for poultry, swine, beef and dairy c...

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

Stay updated on Marshall Wace, LLP with notifications on news.